from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0729/xylB

LFCtreatmentdescriptionclass of inhibitor

0.387

Amikacinug/mL Amikacintranslation

-0.324

Cap5-10ug/mL Capreomycintranslation

-0.221

Rox10-50 ug/mL Roxithromycintranslation

0.079

SM2-5 ug/mL Streptomycintranslation

0.188

Tet5-10 ug/mL Tetracyclinetranslation

1.881

Rif0.2-5ug/mL Rifampicintranscription

0.487

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.193

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.250

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.514

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.800

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.568

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.527

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.793

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.630

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.690

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.968

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.190

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.689

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.258

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.279

KCN5-20 ug/mL Potassium cyaniderespiration

-0.254

NaN30.2-2 mM Sodium aziderespiration

-0.737

Nigericin50 uM Nigericinrespiration

0.180

TRC10-150 ug/mL Triclosanrespiration

-0.293

TRZ10-25 ug/mL Thioridazinerespiration

0.595

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.107

menadione6-10 ug/mL Menadionerespiration

-0.060

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.029

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.914

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.355

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.380

NRP_1Non-replicating persistence stage 1dosRassociated

0.271

Amp0.2mg/mL AmpicillincellWall

0.112

Cephalexin20-100 ug/mL CephalexincellWall

-0.170

Cerulenin0.32-5 ug/mL CerulenincellWall

0.924

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.648

EMB10-20 ug/mL EthambutolcellWall

-0.211

Eta12-40 ug/mL EthionamidecellWall

-0.151

INH0.2-0.4 ug/mL IsoniazidcellWall

0.636

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.676

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.379

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.541

BZA0.12 mg/mL BenzamidearomaticAmides

0.748

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.290

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.885

H2O24 mM hydrogen peroxideDNAdamaging

0.087

Levo10 ug/mL LevofloxacinDNAdamaging

0.799

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.081

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.599

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.165

UVUV-irradiationDNAdamaging

-0.248

ARP41-4 ug/mL Antitubercular compound ARP4?

0.033

Antimycin12.5-50 ug/mL Antimycin A?

-0.620

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.140

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.103

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.303

PA8240.2-2 ug/mL PA-824?

-1.130

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.053

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.176

Verapamil50 uM Verapamil?

-0.851

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.213

methoxatin10-20 ug/mL Methoxatin?